ArticleAnnals of hematology2022

Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis.

Viviane Jesus Torres de Lima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.